Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database
Author:
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2010.01771.x/fullpdf
Reference17 articles.
1. Zolmitriptan 5 mg nasal spray: Efficacy and onset of action in the acute treatment of migraine - results from phase 1 of the REALIZE Study;Gawel;Headache.,2005
2. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies;Winner;Mayo Clin Proc.,2003
3. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine;Landy;Int J Clin Pract.,2004
4. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial;Ho;Lancet.,2008
5. Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine;Ho;Neurology.,2008
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans;Handbook of Clinical Neurology;2024
2. Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review;Neurology and Therapy;2023-08-05
3. Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review;Cureus;2023-02-21
4. Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial;Neurology and Therapy;2022-09-22
5. Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies;Headache: The Journal of Head and Face Pain;2019-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3